Business
In the three way takeover battle Mylan is getting nervous.
Hi, what are you looking for?
Jewish Business News
All posts tagged "Teva Pharmaceutical Industries"
Business
Teva Pharmaceutical Industries Ltd. has agreed to pay $1.2 billion in a settlement with the U.S. Federal Trade Commission (FTC), resolving claims that Cephalon...
Business
Teva Pharmaceutical Industries Ltd, an Israeli-based company, has acquired a 1.35 percent stake in Mylan through purchases on the open market, increasing pressure on...
Business
Teva CFO Eyal Desheh told Merrill Lynch that it could secure antitrust clearance for the takeover in 4-7 months.
Business
Bloomberg reports Mylan chairman Robert Coury as telling investors he is prepared to reduce Perrigo shareholders' risk
Business
Teva declined the chance because it does not operate in the store-brand OTC market, Perrigo's main activity.
Business
Reuters Exclusive: Generics drugmaker Mylan NV (MYL.O), which is in the middle of a three-way takeover battle, has said it is unwilling to...
Leadership & A-List
The Teva shareholder and digital printing pioneer thinks Teva should be investing in innovation, not cheap commodity drugs.
Business
Mylan's filing on executive compensation reveals much higher pay than at Teva.
Business
Julius Baer analyst Lilian Montero insists it's illogical for Mylan to remain independent.